Opioid drugs; prescriber shall discuss with patient before prescribing, the risks of the drugs and available alternatives.
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Opioids; require health care professionals to discuss opioid use prior to prescription of Schedule II controlled substances, exceptions provided
Controlled dangerous substances; authorizing divided quantities for certain acute pain opioid prescriptions. Effective date.
controlled substances prescription monitoring program
Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.
Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.